v3.26.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Oct. 31, 2025
Jun. 30, 2026
Jul. 31, 2025
Jun. 30, 2025
Subsidiary, Sale of Stock [Line Items]        
Common stock shares authorized   10,000,000,000   10,000,000,000
Preferred stock shares authorized   50,000,000   50,000,000
Preferred stock shares, par value   $ 0.001   $ 0.001
Common stock shares, par value   $ 0.001   $ 0.001
Preferred stock outstanding   0   0
Proceeds from private placement $ 2      
Common stock shares subscription       7,744,445
Common share, issued   1,304,292,407 7,744,445 1,262,680,891
Common share, outstanding   1,304,292,407   1,262,680,891
Non Employees [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of share issued during period   279,000    
Third Tranches [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of share issued during period   1,350,000    
Aegis Ventures Limited [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of share issued during period   4,656,550    
Private Placement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of share issued during period   7,744,445    
Ergon Purchase Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Stock purchase agreement discount percentage 5.00%